A PHASE 1/2 OPEN LABEL EXTENSION STUDY OF GIVOSIRAN, AN INVESTIGATIONAL RNAI THERAPEUTIC, IN PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA R. Marchi; L. Duarte; S. P; R. D; A. Ke; B. Hl; S. E; H. P; B. M; E. Al;